Yanan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yanan Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jian-Bin Wang
Department of Thoracic Surgery The First Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China
1 shared publication Jiangbo Jin
Department of Thoracic Surgery, The First Affifiliated Hospital of Nanchang University, Nanchang City, China
1 shared publicationJiapeng Lei
School of Basic Medical Sciences, Nanchang Medical College, Nanchang City, China
1 shared publicationLonghua Sun
Departments of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang City, China
1 shared publicationMingxi Gan
School of Basic Medical Sciences, Nanchang University, Nanchang City, China
1 shared publicationSong Zhang
Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, China
1 shared publication
Latest Publications
- Open Access
- 27 December 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (12) , 1-13
4EBP1 senses extracellular glucose deprivation and initiates cell death signaling in lung cancer
Nutrient-limiting conditions are common during cancer development. The coordination of cellular glucose levels and cell survival is a fundamental question in cell biology and has not been completely understood. 4EBP1 is known as a translational repressor to regulate cell proliferation and survival by controlling translation initiation, however, whether 4EBP1 could participate in tumor survival by other mechanism except for translational repression function, especially under glucose starvation conditions remains unknown. Here, we found that protein levels of 4EBP1 was up-regulated in the central region of the tumor which always suffered nutrient deprivation compared with the peripheral region. We further discovered that 4EBP1 was dephosphorylated by PTPMT1 under glucose starvation conditions, which prevented 4EBP1 from being targeted for ubiquitin-mediated proteasomal degradation by HERC5. After that, 4EBP1 translocated to cytoplasm and interacted with STAT3 by competing with JAK and ERK, leading to the inactivation of STAT3 in the cytoplasm, resulting in apoptosis under glucose withdrawal conditions. Moreover, 4EBP1 knockdown increased the tumor volume and weight in xenograft models by inhibiting apoptosis in the central region of tumor. These findings highlight a novel mechanism for 4EBP1 as a new cellular glucose sensor in regulating cancer cell death under glucose deprivation conditions, which was different from its classical function as a translational repressor.
- 27 December 2022
- Published by Springer Nature in Cell Death & Disease
- Vol. 13 (12) , 1-13
Open Access4EBP1 senses extracellular glucose deprivation and initiates cell death signaling in lung cancer
Nutrient-limiting conditions are common during cancer development. The coordination of cellular glucose levels and cell survival is a fundamental question in cell biology and has not been completely understood. 4EBP1 is known as a translational repressor to regulate cell proliferation and survival by controlling translation initiation, however, whether 4EBP1 could participate in tumor survival by other mechanism except for translational repression function, especially under glucose starvation conditions remains unknown. Here, we found that protein levels of 4EBP1 was up-regulated in the central region of the tumor which always suffered nutrient deprivation compared with the peripheral region. We further discovered that 4EBP1 was dephosphorylated by PTPMT1 under glucose starvation conditions, which prevented 4EBP1 from being targeted for ubiquitin-mediated proteasomal degradation by HERC5. After that, 4EBP1 translocated to cytoplasm and interacted with STAT3 by competing with JAK and ERK, leading to the inactivation of STAT3 in the cytoplasm, resulting in apoptosis under glucose withdrawal conditions. Moreover, 4EBP1 knockdown increased the tumor volume and weight in xenograft models by inhibiting apoptosis in the central region of tumor. These findings highlight a novel mechanism for 4EBP1 as a new cellular glucose sensor in regulating cancer cell death under glucose deprivation conditions, which was different from its classical function as a translational repressor.